📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-13 15:02
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
31 announcements match the current filters (relevance ≥ 5).
Aarti Industries Signs 10+ Year ₹1,500 Cr Supply Agreement with Global Chemical Major
Aarti Industries has entered into a 10+ year strategic manufacturing and supply agreement with a leading global specialty chemical company (via its domestic subsidiary). The contract represents an aggregate revenue potential of about ₹1,500 crore over its 10+ year duration (~₹150 crore annually, or ~1.7% of TTM revenue of ₹9,011 crore). Under the contract, Aarti Industries will set up, commission, and operate a dedicated manufacturing facility using the customer's proprietary process technology to produce specialty chemicals for high-performance applications.
Confidence: HIGH
What changedAarti Industries executed a dedicated 10+ year contract manufacturing and supply agreement with an international specialty chemical major's domestic subsidiary.
Why it mattersProvides long-term revenue visibility of ~₹150 crore annually and deepens client relationships through customer-proprietary technology, expanding high-performance specialty chemical offerings.
Total contract value: Rs. 1500 croresContract tenure: 10+ yearsOrder vs TTM revenue: ~16.6% (total) / ~1.7% (annualized)
📅 Short termPositive sentiment driver for the stock, highlighting continuing client wins despite broader industry pressures.
📈 Long termAdds sticky, long-term revenue streams through dedicated capacity and proprietary technology integration, supporting operating leverage once commercialized.
⚠ Risk flags
- Project execution and commissioning timeline risks for the dedicated unit
- Annual revenue contribution (~₹150 crore) is relatively modest (~1.7% of TTM revenue)
Key Highlights
Revenue potential of about ₹1,500 crores over a 10+ years tenure
Contract awarded by the domestic subsidiary of a leading international entity
Company to build, commission, and operate a dedicated manufacturing facility
Product will use the customer's proprietary process technology for high-performance applications
👀 What to Watch
Track management disclosures regarding the capex required, financing structure, and commissioning timeline for the dedicated facility in upcoming quarterly earnings calls.
Aarti Industries signs 10+ year ₹1,500 Cr supply deal with global specialty chemical major
Aarti Industries has entered into a 10+ year dedicated manufacturing and supply contract with a global specialty chemical firm with an estimated revenue potential of ₹1,500 crore (~$150 million). AIL will commission and operate a dedicated manufacturing setup in India using the customer's proprietary technology, involving a capex of under US$25 million (~₹210 crore). Commercial operations are scheduled to commence in FY2028-29, subject to regulatory approvals. The contract adds an annualized revenue potential of ~₹150 crore, which represents ~1.7% of its TTM revenue of ₹9,011 crore.
Confidence: HIGH
What changedAarti Industries has secured a long-term dedicated supply contract with a new global customer and will build a dedicated production facility.
Why it mattersProvides multi-year revenue visibility, strengthens custom synthesis and contract manufacturing credentials, and requires modest capex (<$25M) backed by a structured financial model.
Total contract value: ₹1,500 croresContract duration: 10+ yearEstimated capex: less than US$25 millionAnnualized contract value vs TTM revenue: ~1.7%Target commercialization: FY2028–29
📅 Short termPositive sentiment driver highlighting contract execution capability, but no immediate impact on earnings as revenue starts in FY29.
📈 Long termExpands Aarti's high-value, dedicated manufacturing portfolio and deepens integration with global multinational chemical companies.
⚠ Risk flags
- Execution timeline spans over two years (FY29 start)
- Customer concentration within the dedicated facility
- Subject to applicable statutory approvals
Key Highlights
10+ year dedicated manufacturing and supply agreement signed with a leading global specialty chemical company
Estimated cumulative revenue potential of approximately ₹1,500 crore (~US$150 million) over the contract term
Dedicated capex of less than US$25 million under a structured financial arrangement
Commercial operations expected to commence in FY2028-29
👀 What to Watch
Monitor regulatory approvals, site selection, and construction progress leading up to the targeted FY29 commercialization, along with further details on the structured capex financing.
Aarti Industries Seeks Shareholder Nod for Up to ₹1,000 Cr Fundraise at Oct 31 EGM
Aarti Industries Limited has issued an Extraordinary General Meeting (EGM) notice scheduled for October 31, 2026, to seek shareholder approval for raising funds up to ₹1,000 crore. The capital raise is planned via private placement, Qualified Institutions Placement (QIP), or other permissible equity-linked instruments. Relative to the company's financials, the ₹1,000 crore ceiling equals ~5.7% of its current market capitalization of ₹17,569 crore and ~16.7% of its net worth of ₹5,972 crore. The proceeds could help support ongoing capital expenditures like Zone 4 Jhagadia expansion and manage its current debt load of ₹4,965 crore.
Confidence: HIGH
What changedAarti Industries has formally dispatched the notice for an EGM to approve an enabling resolution to raise up to ₹1,000 crore.
Why it mattersEnables the company to strengthen its balance sheet and fund strategic expansions like Jhagadia Zone 4, while potentially causing mild equity dilution (around 5-6% at current valuations).
Proposed fundraise ceiling: ₹1,000 croreFundraise vs Market Cap: ~5.7%Fundraise vs Net Worth: ~16.7%EGM date: October 31, 2026Max permitted QIP discount: 5%
📅 Short termNeutral. The filing represents an enabling resolution; market impact will depend on the timing, pricing discount, and chosen issuance route once launched.
📈 Long termPotentially helps de-lever or fund planned capex expansions without over-stretching debt, supporting long-term volume ramp-up.
⚠ Risk flags
- Equity dilution risk if issued via equity/QIP
- Timing and pricing uncertainty depending on market conditions
Key Highlights
Proposed fundraising of up to ₹1,000 crore through QIP, private placement, or convertible securities
Extraordinary General Meeting (EGM) scheduled for Saturday, October 31, 2026 at 11:00 a.m. IST via VC/OAVM
Pricing allowed up to a maximum 5% discount on the Floor Price under SEBI ICDR regulations for QIP
Notice issued following authorization dated October 1, 2026
👀 What to Watch
Track the outcome of the October 31, 2026 EGM voting and monitor subsequent board announcements regarding the exact instrument, timing, and dilution pricing of the issue.
Aarti Industries Approves Enabling Resolution to Raise up to ₹1,000 Cr
Aarti Industries' Board of Directors has approved an enabling resolution to raise funds up to ₹1,000 crore. The capital may be raised via equity shares, convertible debentures, composite NCDs with warrants, QIP, rights issue, or preferential issues. At ₹1,000 crore, the fundraise represents approximately 5.9% of the company's current market capitalization of ₹16,881 crore and 16.7% of its net worth. The proposal is subject to necessary statutory, regulatory, and shareholder approvals.
Confidence: HIGH
What changedThe Board granted an enabling approval to raise capital up to ₹1,000 crore across various permissible debt/equity routes.
Why it mattersProvides financial headroom to fund upcoming expansions (like Zone 4 Jhagadia) or pare down existing debt of ₹4,965 crore, though equity issuance could lead to mild dilution.
Approved fundraise limit: up to Rs. 1,000 CroresFundraise vs Market Cap: ~5.9%Fundraise vs Net Worth: ~16.7%
📅 Short termLimited direct impact as this is an enabling resolution; market will wait for terms of issuance, structure, and potential dilution details.
📈 Long termStrengthens balance sheet flexibility and assists in funding strategic capex, though equity dilution is a structural consideration if equity route is chosen.
⚠ Risk flags
- Potential equity dilution if raised via QIP/equity shares
- Shareholder approval is pending
Key Highlights
Board approved enabling resolution for fund raising up to ₹1,000 Crores
Instruments include equity shares, convertible debentures, warrants, QIP, or debt securities
Fundraise amount equals ~5.9% of current market cap of ₹16,881 Cr
Requires approval from company shareholders and relevant statutory authorities
👀 What to Watch
Track the upcoming shareholder voting outcome and monitor disclosures regarding the specific mode of issuance, pricing, and planned capital deployment (such as deleveraging vs Jhagadia Zone 4 capex).
Aarti Industries AGM: Targets ₹800-1,200 Cr EBITDA Drivers by FY28; MMA Scaled to 360 kTPA
Aarti Industries presented its 43rd AGM update outlining key operational and growth milestones, including FY26 revenue of ₹9,018 crore (up 12%) and EBITDA of ₹1,172 crore (up 15%). The company outlined near-term (FY26-28) EBITDA drivers totaling ₹800-1,200 crore, split across cost optimisation (₹150-200 crore), volume/margin ramp-up (₹350-550 crore), and capex-led growth (₹300-450 crore). Capacity updates include scaling MMA/fuel additives to 360 kTPA in Q1 FY27 and plans to invest ₹200-250 crore over two years in a 15-year backward integration project. Additionally, a $150 million medium-term supply contract till March 2030 with a global agrochemicals innovator will ramp up volumes from FY27.
Confidence: HIGH
What changedAarti Industries published its 43rd AGM presentation detailing project execution timelines, contract wins, and a quantified ₹800-1,200 crore near-term EBITDA bridge.
Why it mattersProvides visibility on volume-led growth and backward integration margin enhancements following a volatile FY26 marked by US tariffs and elevated debt levels.
FY26 Consolidated Revenue: ₹9018 CrFY26 Consolidated EBITDA: ₹1172 CrNear-term EBITDA growth bridge (FY26-28): ₹800-1,200 croreAgrochemical supply contract value: US$ 150mnBackward integration planned capex: ₹200–250 croreMMA capacity in Q1 FY27: 360 kTPA
📅 Short termAGM presentations are generally informative; near-term focus will center on quarterly earnings performance and working capital normalisation after raw material price run-ups.
📈 Long termThe scaling of MMA, completion of Zone 4, and long-term contracts offer structural operating leverage, though return ratios depend on managing high debt (₹4,965 crore) and competitive pressure from China.
⚠ Risk flags
- Exposure to US tariffs and aggressive Chinese dumping in key product lines like PDA
- Rising debt and working capital levels due to raw material volatility from geopolitical conflicts
- Execution and ramp-up risks for Zone 4 and JV projects expected in FY27
Key Highlights
Targets ₹800-1,200 crore cumulative EBITDA growth drivers across three pillars over FY26-FY28
MMA/Fuel Additives capacity expanded from 200 kTPA to 290 kTPA in FY26 and reached 360 kTPA in Q1 FY27
Signed a $150 million multi-year supply agreement running through March 2030 with a top agrochemicals major
Planning ₹200-250 crore capex over two years for upstream backward integration under an extended 15-year contract
DCB debottlenecking to 140 kTPA underway; Zone 4 Jhagadia commercialisation scheduled for FY27
👀 What to Watch
Track the commercialisation and ramp-up of Zone 4 Jhagadia and JV projects in FY27, along with gross margin progression against raw material inflation and tariffs.
Aarti Industries Commissions Phase I of Zone IV Project at Jhagadia, Gujarat
Aarti Industries has announced the commissioning of Phase I of its Zone IV expansion project at Jhagadia, Gujarat on September 7, 2026. This phase brings Calcium Chloride, PEDA (2-Phenyl Ethyl Diethyl Aniline), and a section of its Multipurpose Plant (MPP) on stream to strengthen downstream integration into agrochemicals and energy additives. The company plans to progressively commercialize all remaining manufacturing blocks within Zone IV during FY27. Following commissioning, management's focus will shift to commercial qualification, customer approvals, and capacity ramp-up.
Confidence: HIGH
What changedAIL has transitioned Phase I of its Zone IV Jhagadia site from construction to active commissioning across three key product lines.
Why it mattersEnhances downstream integration into higher-margin niche chemistries (PEDA and energy additives), supporting volume growth and operating leverage against AIL's ₹9,011 Cr TTM revenue base.
Project location: Jhagadia, GujaratCommissioning date: September 7, 2026Full Zone IV commercialisation target: During this fiscal year (FY27)Existing manufacturing plants: 16R&D scientists: 250+
📅 Short termNear-term sentiment is supported by milestone execution; however, revenue contribution will scale gradually as commercial qualification and customer trials proceed.
📈 Long termDeepens Aarti's competitive moat in complex chemistries and value-added downstream applications, helping offset pricing pressures in commoditized segments.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Ramp-up delays or slower-than-expected customer qualification cycles.
- Ongoing margin pressure from global chemical pricing dynamics and Chinese dumping.
Key Highlights
Commissioned Phase I of Zone IV at Jhagadia on September 7, 2026, encompassing Calcium Chloride, PEDA, and a Multipurpose Plant.
PEDA expands the ethylation platform downstream, building on existing 2,6-diethyl aniline capabilities for agrochemical applications.
On track to progressively commercialize all remaining manufacturing blocks within Zone IV during this fiscal year (FY27).
Expansion adds to Aarti's network of 16 manufacturing plants, 4 R&D centres, and portfolio of 100+ specialty chemical products.
👀 What to Watch
Track customer qualification timelines, volume ramp-up milestones in upcoming quarterly earnings, and updates on the commercialization of remaining Zone IV blocks across FY27.
AARTIIND Q1 FY27: 260% PAT Growth to ₹155 Cr; ₹700-800 Cr FY27 Capex on Track
Aarti Industries reported a robust Q1 FY27 with revenue growing 41% YoY to ₹2,627 crore and PAT surging 260% to ₹155 crore, driven by product mix optimization and inventory gains. Despite a significant drop in West Asia revenue share from 15% to 2% due to regional conflict, the company successfully redirected volumes to other markets. Management maintained its FY27 capex guidance of ₹700-800 crore, with ₹180 crore already deployed in Q1. Key growth projects, including the Zone 4 expansion, face minor 3-6 month delays but remain slated for phased commissioning within FY27.
Confidence: HIGH
What changedThe company has successfully navigated geopolitical disruptions by redirecting export volumes and is transitioning from a high-capex phase to a high-growth execution phase.
Why it mattersThe strong earnings growth despite high raw material costs (Benzene, Aniline) and regional conflicts demonstrates operational resilience and the ability to pass through costs in core segments.
Q1 FY27 Revenue: ₹2,627 crQ1 FY27 PAT Growth (YoY): 260%FY27 Capex Guidance: ₹700-800 crFuel Additives Capacity: 360 KTPACapex vs TTM Revenue: ~9.6%
📅 Short termPositive momentum is expected due to the significant earnings beat and EBITDA growth, though high working capital requirements from elevated feedstock prices remain a factor to watch.
📈 Long termStructural growth is supported by capacity expansions in Zone 4 and fuel additives, alongside new JVs in specialty chemicals and plastic recycling, aiming for higher margins post-FY27.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical conflict in West Asia impacting export logistics
- 3-6 month delays in major project commissioning
- High raw material price volatility (Benzene, Sulphur, Methanol)
Key Highlights
Q1 FY27 PAT surged 260% YoY to ₹155 crore, while EBITDA grew 79% to ₹385 crore.
Fuel additives capacity expanded from 290 KTPA to 360 KTPA to diversify geographic reach.
FY27 Capex guidance maintained at ₹700-800 crore, representing approximately 9.6% of TTM revenue.
West Asia revenue contribution fell sharply to 2% from 15% due to geopolitical tensions.
Zone 4 project commissioning expected in FY27 with a 3-6 month delay due to labor and war-related issues.
👀 What to Watch
Investors should monitor the commissioning of the Augene Chemicals JV in Q2 FY27 and the execution timeline of the Zone 4 project, as these are critical for volume ramp-up in FY28 and FY29.
57% YoY Revenue Growth in Q1 FY27; Fuel Additive Capacity Reaches 360 kTPA
Aarti Industries reported a strong YoY performance for Q1 FY27 with revenue growing 57% to ₹2,422 Cr, although it declined 17% sequentially due to West Asia supply chain disruptions. Profitability saw a sharp jump with PAT up 260% YoY, supported by inventory monetization and FX gains. The company successfully expanded its fuel additive capacity from 290 to 360 kTPA in July 2026. However, management noted a 2-quarter delay in Zone IV projects and a significant drop in Middle East revenue contribution from 15% to 2% due to regional conflict.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and provided an update on its capacity expansion roadmap, including the completion of a fuel additive unit and delays in other major projects.
Why it mattersThe expansion in fuel additives (now 38% of revenue) is a key growth driver, while the FY28 EBITDA guidance suggests a significant planned scale-up from the current TTM EBITDA of approximately ₹1,166 Cr.
Q1 FY27 Revenue: ₹2422 CrYoY Revenue Growth: 57%Fuel Additive Capacity: 360 kTPAMiddle East Revenue Share: 2%FY28 EBITDA Target: ₹1800 - 2200 CrQ1 Revenue vs TTM Revenue: ~29%
📅 Short termThe strong YoY profit growth and capacity completion are positive signals, though the sequential revenue decline and project delays may temper immediate stock momentum.
📈 Long termThe structural shift toward energy additives and the FY28 EBITDA target indicate a clear growth trajectory, provided the company can navigate geopolitical risks and project execution delays.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical risk (West Asia conflict impacting 13% of historical revenue)
- Project execution delays (Zone IV delayed by 2 quarters)
- Chinese dumping and global pricing pressure on margins
Key Highlights
Revenue for Q1 FY27 stood at ₹2,422 Cr, representing a 57% YoY increase but a 17% QoQ decline.
Fuel additive capacity (Methylation) expanded from 290 to 360 kTPA as of July 2026.
Middle East revenue share plummeted to 2% from a historical ~15% due to the West Asia conflict.
Management set a long-term EBITDA target of ₹1,800-2,200 Cr by FY28.
Zone IV projects at Jhagadia are delayed by 2 quarters due to labor constraints and geopolitical issues.
👀 What to Watch
Monitor the volume ramp-up in the newly expanded 360 kTPA fuel additive segment and the execution of delayed Zone IV projects in FY27. Investors should also track the company's ability to maintain margins (currently 12-14%) amidst Chinese dumping and high input costs.
Aarti Industries to Incorporate 100% Wholly Owned Subsidiary in China
Aarti Industries' Board approved the incorporation of a wholly owned subsidiary in China on July 30, 2026. This strategic move comes as the company manages a TTM revenue of Rs 8,300 Cr and navigates significant headwinds, including 50% US tariffs on products representing 15-20% of its revenue. While the specific capital outlay was not disclosed, the move likely aims to strengthen the company's supply chain or market presence in a region that currently exerts pricing pressure through dumping. Investors should note the company's current debt level of Rs 4,965 Cr and an OPM of 14.0%.
Confidence: MEDIUM
What changedThe company has formally decided to establish a legal corporate presence in China through a new wholly owned subsidiary.
Why it mattersEstablishing a base in China is a strategic move to potentially mitigate supply chain risks or better compete in a market that is currently a major source of pricing pressure and dumping in the chemicals sector.
Subsidiary Ownership: 100%TTM Revenue: Rs 8300 CrRevenue exposed to US Tariffs: 15-20%Total Debt: Rs 4965 Cr
📅 Short termNeutral; the announcement is a preliminary board approval with no immediate impact on cash flows or operations.
📈 Long termPotentially strategic for supply chain integration or market expansion, though it introduces exposure to Chinese regulatory and geopolitical risks.
⚠ Risk flags
- Geopolitical risks
- Regulatory compliance in a foreign jurisdiction
- Lack of initial financial disclosure regarding investment size
Key Highlights
Board approved the incorporation of a 100% wholly owned subsidiary in China on July 30, 2026.
Company currently faces 50% US tariffs on products contributing 15-20% of total revenue.
TTM revenue stands at Rs 8,300 Cr with a net profit of Rs 419 Cr as of FY26.
Operating profit margins (OPM) are currently at 14.0% amid global pricing pressures.
👀 What to Watch
Monitor subsequent filings for the 'Additional Information' disclosure to understand the subsidiary's capital commitment and whether its focus is on manufacturing, sourcing, or trading.
260% PAT Growth in Q1 FY27; Fuel Additive Capacity Expanded to 360 KTPA
Aarti Industries reported a strong start to FY27 with revenue growing 41% YoY to ₹2,627 crore and PAT surging 260% YoY to ₹155 crore. EBITDA grew 79% YoY to ₹385 crore, driven by an optimized product mix and inventory gains despite volume degrowth in some segments. The company successfully expanded its Fuel Additives capacity from 290 KTPA to 360 KTPA in July 2026. However, key expansion projects in Zone IV and chlorotoluene value chains are facing a 4-6 month delay due to labor constraints.
Confidence: HIGH
What changedAarti Industries delivered a significant earnings beat with 260% PAT growth and completed a 24% capacity expansion in its fuel additives segment.
Why it mattersThe strong margin recovery and capacity expansion signal resilience against global supply chain headwinds and support the company's shift toward high-value specialty chemicals.
Revenue (Q1 FY27): ₹2627 crorePAT Growth (YoY): 260%Fuel Additive Capacity: 360 KTPAFY27 Capex Guidance: ₹700-800 croreQ1 Capex vs TTM Revenue: ~2.17%
📅 Short termThe stock may react positively to the sharp recovery in profitability and the successful capacity expansion in fuel additives.
📈 Long termStructural growth is supported by the ramp-up of new capacities and entry into energy additives, though high debt (D/E 0.83) and project delays remain key monitorables.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Labor constraints causing 4-6 month delays in key projects
- Geopolitical tensions in West Asia impacting export volumes
- High debt-to-equity ratio of 0.83
Key Highlights
Revenue from operations increased 41% YoY to ₹2,627 crore for Q1 FY27.
Profit After Tax (PAT) surged 260% YoY to ₹155 crore.
Fuel Additives capacity successfully expanded from 290 KTPA to 360 KTPA in July 2026.
FY27 Capex guidance maintained at ₹700–800 crore, with ₹180 crore spent in Q1.
Zone IV expansion and chlorotoluene projects delayed by 4-6 months due to labor constraints.
👀 What to Watch
Monitor the commissioning of the MPP plants in Q2 FY27 and the volume recovery in the Energy business following West Asia disruptions. Track the execution of the Zone IV expansion, which is now phased over the next three quarters.
Aarti Industries to Incorporate Wholly Owned Subsidiary in China
Aarti Industries' Board of Directors approved the incorporation of a 100% wholly owned subsidiary in China on July 30, 2026. This strategic move occurs while the company manages a TTM revenue of ₹8,300 Cr and faces margin pressure from Chinese dumping and 50% US tariffs on 15-20% of its revenue. Specific investment amounts and business objectives for the new entity were not disclosed in the initial filing. Investors should note that further details are expected once the incorporation process is finalized.
Confidence: MEDIUM
What changedAarti Industries is establishing a formal corporate presence in China, moving from a purely competitive/export relationship to having a local subsidiary.
Why it mattersEstablishing a base in China could help the company mitigate supply chain risks or better navigate the 'Chinese dumping' that currently limits its pricing power and keeps margins in the 12-14% range.
Ownership Stake: 100%TTM Revenue: ₹8300 CrUS Tariff Exposure: 15-20% of revenueBoard Approval Date: July 30, 2026
📅 Short termNeutral impact expected in the immediate term as the filing lacks financial specifics regarding capital outlay.
📈 Long termPotentially significant for supply chain integration or market access, though it introduces geopolitical and regulatory risks inherent to operating in China.
⚠ Risk flags
- Geopolitical risk
- Regulatory compliance in China
- Potential for capital misallocation
Key Highlights
Board approval for 100% wholly owned subsidiary in China granted on July 30, 2026
Company currently manages ₹8,300 Cr TTM revenue with a 14% operating margin
Move comes amid 50% US tariffs impacting 15-20% of the company's revenue base
Strategic recalibration follows reported margin compression due to global pricing pressure
👀 What to Watch
Watch for the follow-up disclosure regarding the subsidiary's authorized capital and specific business activities (e.g., manufacturing vs. trading) to assess the scale of investment relative to the ₹17,613 Cr market cap.
AARTIIND Q1 FY27: PAT Surges 260% to ₹155 Cr; Revenue Up 41% to ₹2,627 Cr
Aarti Industries delivered a strong Q1 FY27 with revenue reaching ₹2,627 crore, a 41% YoY increase and significantly higher than the previous quarter's ₹2,205 crore. PAT grew 260% YoY to ₹155 crore, driven by an optimized product mix and inventory gains despite geopolitical disruptions in West Asia. While EBITDA grew 79% YoY to ₹385 crore, the company reported a 4-6 month delay in its Zone IV and chlorotoluene projects due to labor constraints. Fuel additive capacity was successfully expanded by 24% to 360 KTPA in July 2026.
Confidence: HIGH
What changedThe company has demonstrated a sharp recovery in profitability and revenue growth compared to FY26 levels, alongside a successful capacity expansion in fuel additives.
Why it mattersThe results indicate strong operating leverage and the ability to pass on costs/manage inventory despite global headwinds, though persistent project delays could slow the long-term growth trajectory.
Q1 Revenue: ₹2627 crorePAT Growth (YoY): 260%EBITDA Growth (YoY): 79%Fuel Additives Capacity: 360 KTPAQ1 Revenue vs TTM Revenue: 31.6%FY27 Capex Guidance: ₹700-800 crore
📅 Short termThe stock is likely to react positively to the significant YoY earnings beat and the 13% QoQ EBITDA growth.
📈 Long termStructural growth is supported by the shift toward energy additives (now 36% of revenue) and ongoing expansions, though high debt and execution delays remain long-term monitoring points.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- 4-6 month delay in key expansion projects (Zone IV)
- Geopolitical tensions in West Asia impacting energy business volumes
- High debt-to-equity ratio of 0.83
Key Highlights
Revenue of ₹2,627 crore represents approximately 31.6% of the total TTM revenue in a single quarter.
PAT surged 260% YoY to ₹155 crore, compared to ₹43 crore in the same quarter last year.
Fuel Additives capacity increased from 290 KTPA to 360 KTPA as of July 2026.
FY27 Capex guidance maintained at ₹700–800 crore, with ₹180 crore already deployed in Q1.
Zone IV and chlorotoluene projects face a 4-6 month delay, now expected to commission over the next three quarters.
👀 What to Watch
Investors should monitor the volume recovery in Q2 FY27 as guided by management and track the commissioning timeline of the MPP plants. The 4-6 month delay in Zone IV projects is a key execution risk to watch regarding FY27-28 growth targets.
Aarti Industries shifts to professional management; CEO Suyog Kotecha appointed MD
Aarti Industries has announced a significant leadership transition effective October 1, 2026, moving from a promoter-led to a professional-led management structure. Current CEO Suyog Kotecha will assume the role of Managing Director for a 5-year term, while three promoter directors—Rajendra, Rashesh, and Renil Gogri—will transition from Executive to Non-Executive roles. The promoters will continue to provide strategic oversight as Chairman and Vice-Chairmen. This transition occurs as the company manages a ₹8,300 Cr revenue base and navigates global margin pressures.
Confidence: HIGH
What changedThe company is transitioning its top executive leadership from the promoter family to a professional Managing Director, effective October 1, 2026.
Why it mattersThis signals a maturing governance model for a ₹17,613 Cr market cap company, potentially improving operational agility while retaining promoter strategic guidance during a period of high debt (₹4,965 Cr).
Effective Date of Change: October 1, 2026MD Appointment Term: 5 yearsTTM Revenue: ₹8,300 CrPromoter Holding: 42.1%Debt-to-Equity Ratio: 0.83
📅 Short termThe market is likely to view the structured succession plan positively as it removes uncertainty regarding leadership continuity.
📈 Long termStructural shift toward professional management could lead to better capital allocation and operational efficiencies as the company targets FY27 capacity commercialization.
⚠ Risk flags
- Potential for strategic friction between professional MD and non-executive promoter chairmen
- Execution risk during the transition period
Key Highlights
Transition of 3 promoter directors to Non-Executive roles effective October 1, 2026
Appointment of current CEO Suyog Kotecha as Managing Director for a 5-year term
Promoter holding remains stable at 42.1% as of March 2026
Transition aligns with a ₹8,300 Cr TTM revenue scale and 14% OPM environment
Board meeting for these approvals concluded at 6:30 pm on July 30, 2026
👀 What to Watch
Watch for the smooth handover of operational responsibilities by October 2026 and monitor if the professional leadership can improve the current 7% ROCE through better capacity utilization.
₹155 Cr PAT (+260% YoY); Revenue up 42% in Q1 FY27 Results
Aarti Industries reported a strong start to FY27 with consolidated net revenue growing 42.4% YoY to ₹2,387 Cr. Net profit surged 260% YoY to ₹155 Cr, significantly exceeding the ₹43 Cr reported in the same quarter last year. This growth was achieved despite a 38% YoY increase in finance costs to ₹83 Cr. The company also completed the divestment of its subsidiary Shanti Intermediates for ₹2 Cr, which had a negligible impact on overall operations.
Confidence: HIGH
What changedAarti Industries has shown a sharp recovery in profitability and volume-led revenue growth compared to the low base of the previous year.
Why it mattersThe results indicate strong operating leverage and volume ramp-up, which are critical to offset global pricing pressures and high interest expenses from its ₹4,965 Cr debt.
Consolidated Net Revenue: ₹2,387 CrNet Profit (PAT): ₹155 CrRevenue Growth (YoY): 42.4%Finance Costs: ₹83 CrEPS (Basic): ₹4.27
📅 Short termThe stock is likely to react positively to the significant YoY profit growth and sequential improvement in margins.
📈 Long termLong-term value depends on the successful execution of the energy additives segment and navigating the 'Negative' credit rating outlook through debt reduction or earnings growth.
⚠ Risk flags
- High finance costs (₹83 Cr per quarter)
- Negative credit rating outlook from CRISIL/India Ratings
- Exposure to 50% US tariffs on 15-20% of revenue
Key Highlights
Consolidated Net Revenue increased 42.4% YoY to ₹2,387 Cr from ₹1,676 Cr
Net Profit (PAT) jumped 260.5% YoY to ₹155 Cr compared to ₹43 Cr in Q1 FY26
Finance costs rose to ₹83 Cr from ₹60 Cr in the previous year's quarter
Divested 100% stake in Shanti Intermediates Private Limited for ₹2 Cr on June 23, 2026
Outstanding Commercial Papers (Short Term Debt) stood at ₹600 Cr as of June 30, 2026
👀 What to Watch
Watch for the commercialization of Zone 4 Jhagadia capacities in FY27 and the management's commentary on mitigating the 50% US tariff impact on 15-20% of revenue.
Aarti Industries Promoters Confirm Zero Share Encumbrance for FY 2025-26
Chandrakant Vallabhaji Gogri, representing the promoter group of Aarti Industries Limited, has submitted a formal declaration under SEBI (SAST) Regulations. The disclosure confirms that none of the promoters or promoter group members have encumbered their shares, directly or indirectly, during the financial year 2025-2026. This annual declaration covers a comprehensive list of 145 entities, including individual promoters, family trusts, and corporate bodies. Such transparency ensures that promoter holdings remain unpledged, reducing risks associated with margin calls or forced liquidations.
Key Highlights
Promoter group confirms zero encumbrance on shares for the entire Financial Year 2025-2026.
Declaration submitted in compliance with Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The disclosure encompasses a total of 145 promoter and promoter group entities, including major trusts and subsidiaries.
Confirmation indicates that no promoter shares were pledged as collateral for loans during the period.
👀 What to Watch
Investors can take comfort in the fact that 100% of the promoter holding remains unencumbered, which is a sign of financial stability. No immediate action is required as this is a routine but positive annual compliance filing.
Aarti Industries Achieves EcoVadis Platinum Rating 2026 with 87/100 Score
Aarti Industries has secured the prestigious EcoVadis Platinum Rating for 2026, placing it in the top 1% of companies evaluated globally. The company's sustainability score improved significantly to 87/100, up from 78 in the previous assessment and 38 in 2017. Furthermore, its S&P Global CSA score rose to 78 from 62, ranking it in the 98th percentile of the global chemical sector. These achievements reinforce Aarti's position as a 'Partner of Choice' for global customers who increasingly prioritize ESG-compliant supply chains.
Key Highlights
Achieved EcoVadis Platinum Rating with a score of 87/100, ranking in the top 1% of companies globally.
Sustainability score has seen a 49-point improvement over the last decade, rising from 38 in 2017 to 87 in 2026.
S&P Global CSA score increased to 78 from 62, placing the company in the 98th percentile of the chemical sector.
One of only 37 chemical companies globally included in the S&P Global Sustainability Yearbook 2026.
Highest CSA score among the seven Indian chemical firms included in the Sustainability Yearbook.
👀 What to Watch
Investors should recognize this as a significant competitive advantage that strengthens the company's relationship with global MNCs and may attract ESG-focused institutional capital. The consistent improvement in sustainability metrics reflects high operational standards and long-term risk management maturity.
Aarti Industries Q4 FY26 PAT Jumps 43% to ₹137 Cr; FY27 Capex Guided at ₹700-800 Cr
Aarti Industries reported a robust Q4 FY26 with PAT growing 43% Y-o-Y to ₹137 crore and revenue increasing 9% to ₹2,422 crore. The company demonstrated resilience against geopolitical tensions in the Middle East, which accounts for 9-10% of revenue, by rerouting volumes to other geographies. Management has signaled a shift toward capital efficiency, guiding for a lower capex of ₹700-800 crore in FY27 compared to ₹1,125 crore in FY26. Additionally, the company secured a significant $150 million multi-year supply agreement and a new backward integration contract.
Key Highlights
Q4 FY26 EBITDA grew 29% Y-o-Y to ₹342 crore, while full-year FY26 PAT rose 27% to ₹419 crore.
Secured a $150 million multi-year supply agreement for a critical agrochemical intermediate through March 2030.
Capex for FY27 is projected to decrease to ₹700-800 crore, focusing on high-return niche projects and debt reduction.
Raw material prices for benzene, sulfur, and aniline surged by over 60%, impacting input cost structures.
Zone IV projects, including multipurpose and PEDA plants, are expected to commission in phased stages during FY27.
👀 What to Watch
Investors should take confidence in the company's ability to maintain volume growth and secure long-term contracts despite global volatility. The planned reduction in capex intensity and focus on debt reduction are positive indicators for future free cash flow and return ratios.
Aarti Industries Q4 FY26: Targets ₹1,800-2,200 Cr EBITDA by FY28; MMA Volumes Surge 93% YoY
Aarti Industries reported robust volume growth in Q4 FY26, led by a 93% YoY increase in MMA and 41% in Ethylation, although agrochemical margins remain under pressure. The company has outlined a clear growth roadmap with an EBITDA target of ₹1,800-2,200 Cr by FY28 and a planned FY26 capex of ₹1,125 Cr. Despite a 3-4 month delay in Zone IV projects, the company secured a significant 4-year contract worth $150 million. Finance costs were impacted by a ₹39 Cr forex revaluation, but management aims to keep Debt/EBITDA below 2.5x while targeting over 15% ROCE.
Key Highlights
MMA production volumes grew 93% YoY in Q4 FY26, with capacity expansion to 360 kTPA currently underway.
Signed a new 4-year supply contract with a target revenue of $150 million with an existing customer.
FY26 Capex reached ₹1,125 Cr, focusing on Zone IV, Chlorotoluene, and Multi-Purpose Plant (MPP) projects.
Targeting long-term EBITDA of ₹1,800-2,200 Cr with a Debt/EBITDA ratio of less than 2.5x.
Finance costs included a ₹39 Cr impact from the revaluation of unhedged foreign currency long-term loans.
👀 What to Watch
Investors should focus on the successful ramp-up of new capacities in MMA and Ethylation which are driving volume growth. The long-term EBITDA guidance and high ROCE targets suggest strong recovery potential as agrochemical margins stabilize.
Aarti Industries FY26 PAT Jumps 27% to ₹419 Cr; Secures $150M Global Contract
Aarti Industries reported a resilient performance for FY26 with revenue growing 12% YoY to ₹9,018 Cr and PAT increasing 27% to ₹419 Cr. Despite geopolitical tensions in the Middle East affecting logistics, Q4 EBITDA rose to ₹342 Cr from ₹323 Cr in the previous quarter. The company secured a significant $150 million multi-year supply agreement and initiated a ₹200-250 Cr backward integration project. However, Q4 profitability was slightly impacted by a ₹39 Cr foreign exchange revaluation loss due to INR depreciation.
Key Highlights
Full-year FY26 Revenue reached ₹9,018 Cr, marking a 12% YoY growth.
Annual PAT stood at ₹419 Cr, a significant 27% increase compared to the previous year.
Signed a $150 million multi-year supply agreement for agrochemical intermediates through March 2030.
Q4 EBITDA improved to ₹342 Cr vs ₹323 Cr in Q3 FY26, despite macro headwinds.
Allocated ₹200–250 Cr for a strategic backward integration project under a 15-year contract.
👀 What to Watch
Investors should take confidence in the company's ability to secure long-term high-value contracts and its 27% PAT growth. While Middle East volatility remains a watchpoint for logistics costs, the improving EBITDA run rate and strategic integration projects support a positive long-term outlook.
Aarti Industries Q4 Net Profit Jumps 43% to ₹137 Cr; Recommends ₹1 Dividend
Aarti Industries reported a strong performance for Q4 FY26, with consolidated net profit rising 42.7% year-on-year to ₹137 crore. Consolidated revenue from operations grew by 13.2% to ₹2,206 crore compared to ₹1,949 crore in the same quarter last year. For the full year FY26, the company achieved a net profit of ₹419 crore on a revenue of ₹8,286 crore. The Board has recommended a dividend of ₹1 per share (20% of face value), reflecting steady shareholder returns.
Key Highlights
Consolidated Net Profit for Q4 FY26 increased to ₹137 crore from ₹96 crore in Q4 FY25.
Full-year FY26 Consolidated Revenue grew 14% to ₹8,286 crore from ₹7,269 crore.
Operating margins improved significantly to 14.15% in Q4 FY26 from 11.89% in Q4 FY25.
Board recommended a final dividend of ₹1 per equity share of face value ₹5.
Consolidated EPS for the full year FY26 rose to ₹11.56 from ₹9.13 in the previous year.
👀 What to Watch
The robust double-digit growth in both top-line and bottom-line, coupled with margin expansion, indicates a strong recovery in the specialty chemicals segment. Investors should monitor the sustainability of these margins in upcoming quarters while maintaining a positive outlook on the stock.
